Epirubicin and docetaxel as neoadjuvant treatment of locally advanced breast cancer: a phase II study

被引:0
|
作者
Lombardi, D. [1 ]
Scalone, S. [1 ]
Crivellari, D. [1 ]
La Mura, N. [1 ]
Miolo, G. [1 ]
Murrone, A. [1 ]
Perin, T. [1 ]
Coran, F. [1 ]
Candiani, E. [1 ]
Massarut, S. [1 ]
Veronesi, A. [1 ]
机构
[1] Ctr Riferimento Oncol, I-33081 Aviano, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S229 / S229
页数:1
相关论文
共 50 条
  • [1] Epirubicin and docetaxel as neoadjuvant treatment of locally advanced breast cancer: a phase II study
    Lombardi, Davide
    Scalone, Simona
    Crivellari, Diana
    Magri, Maria Donatella
    La Mura, Nicoletta
    Miolo, GianMaria
    Murrone, Antonio
    Perin, Tiziana
    Coran, Francesco
    Candiani, Ezio
    Massarut, Samuele
    Veronesi, Andrea
    [J]. TUMORI JOURNAL, 2010, 96 (02): : 229 - 233
  • [2] Phase II study of neoadjuvant therapy with epirubicin and docetaxel for women with locally advanced breast cancer.
    Holter, JL
    Tfayli, A
    Venkattapa, S
    Bova, A
    Howard, O
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 98S - 98S
  • [3] A Phase II Trial of Neoadjuvant Gemcitabine, Epirubicin, and Docetaxel as Primary Treatment of Patients With Locally Advanced or Inflammatory Breast Cancer
    Yardley, Denise A.
    Peacock, Nancy W.
    Dickson, Natalie R.
    White, Melissa B.
    Vazquez, Elizabeth R.
    Foust, John T.
    Grapski, Richard
    Hendricks, Linda K.
    Scott, William L.
    Hainsworth, John D.
    [J]. CLINICAL BREAST CANCER, 2010, 10 (03) : 217 - 223
  • [4] A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer
    Yao, Xin
    Hosenpud, Janet
    Chitambar, Christopher R.
    Charlson, John
    Cheng, Yee Chung
    [J]. JOURNAL OF CANCER, 2012, 3 : 145 - 151
  • [5] A phase II trial of docetaxel (taxotere) in combination with epirubicin as neoadjuvant chemotherapy in patients with locally advanced breast cancer
    Fried, G
    Zidan, J
    Epelbaum, R
    Keren-Rosenberg, S
    Basher, W
    Steckelman, I
    Kogan, F
    Haim, N
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 : S69 - S70
  • [6] A phase II study of docetaxel followed by vinorelbine and doxorubicin in the neoadjuvant treatment of locally advanced breast cancer
    Youssef, A. C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Phase II study of neoadjuvant treatment with docetaxel, doxorubicin and capecitabine (ATX) in locally advanced or inflammatory breast cancer
    Khosravi-Shahi, P.
    Mendez, M.
    Quiben, R.
    Palomero, I.
    Izarzugaza, Y.
    Belon, J.
    Garcia-Alfonso, P.
    Perez-Manga, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer
    Gumersindo Pérez Manga
    Parham Khosravi Shahi
    Miguel Méndez Ureña
    Rosa Quiben Pereira
    María Isabel Palomero Plaza
    Yann Izarzugaza Peron
    Ricardo González Del Val
    Joaquín Belón Carrión
    Esperanza Pérez Cañón
    Pilar García Alfonso
    [J]. Breast Cancer, 2010, 17 : 205 - 211
  • [9] Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer
    Perez Manga, Gumersindo
    Khosravi Shahi, Parham
    Mendez Urena, Miguel
    Quiben Pereira, Rosa
    Palomero Plaza, Maria Isabel
    Izarzugaza Peron, Yann
    Gonzalez Del Val, Ricardo
    Belon Carrion, Joaquin
    Perez Canon, Esperanza
    Garcia Alfonso, Pilar
    [J]. BREAST CANCER, 2010, 17 (03) : 205 - 211
  • [10] Phase II study of combined docetaxel, epirubicin, and cyclophosphamide as a neoadjuvant chemotherapy regimen in patients with locally advanced breast cancer in a single institution
    Yao, X.
    Hosenpud, J. R.
    Chitambar, C. R.
    Charlson, J. A.
    Cheng, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)